Two Molecular Forms of Adrenomedullin in Congenital Heart Disease

Pediatric Cardiology

Volumn 24, Issue 6, 2003, Pages 559-565

  Watanabe, K ^a   Nishikimi, T ^b   Takamuro, M ^a   Yasuda, K ^a   Ishikawa, Y ^a   Tanabe, S ^a   Yamada, O ^a   Nagaya, N ^b   Matsuoka, H ^b   Kangawa, K ^a   Echigo, S ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adrenomedullin; Congenital heart disease; Hypoxia; Pulmonary hypertension

Indexed keywords

ADRENOMEDULLIN;

ADOLESCENT; ARTERY RESISTANCE; ARTICLE; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYANOTIC HEART DISEASE; FEMALE; FONTAN PROCEDURE; HUMAN; LUNG BLOOD FLOW; LUNG CIRCULATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIPLE REGRESSION; OXYGEN SATURATION; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PULMONARY ARTERY; PULMONARY HYPERTENSION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADRENOMEDULLIN; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; FEMALE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; MALE; OXYGEN; PEPTIDES; REGRESSION ANALYSIS; VASCULAR RESISTANCE;

EID: 10744226692     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-003-0321-x     Document Type: Article

References (39)

1. Charles CJ, Lainchbury JG, Lewis LK, et al. (1999) The role of adrenomedullin. Am J Hypertens 12:166-173
2. Cormier-Regard S, Nguyen SV, Claycomb WC (1998) Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 273:17787-17792
3. Ebara T, Miura K, Okumura M, et al. (1994) Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol 263:69-73
4. Fukuhara M, Tsuchihashi T, Abe I, Fujishima M (1995) Cardiovascular and neurohormonal effects of intravenous adrenomedullin in conscious rabbits. Am J Physiol 269: R1289-R1293
5. Hall JM, Siney L, Lippton H, Hyman A, Kang-Chang J, Brain SD (1995) Interaction of human adrenomedullin 13-52 with calcitonin gene-related peptide receptors in the microvasculature of the rat and hamster. Br J Pharmacol 114:592-597
6. Heaton J, Lin B, Chang JK, Steinberg S, Hyman A, Lippton H (1995) Pulmonary vasodilation to adrenomedullin: a novel peptide in humans. Am J Physiol 268:H2211-H2215
7. Hinson JP, Kapas S, Smith DM (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21:138-167
8. Ishimitsu T, Nishikimi T, Saito Y, et al. (1994) Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 94:2158-2161
9. Jougasaki M, Wei CM, McKinley LJ, Burnett JC (1995) Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 92:286-289
10. Kakishita M, Nishikimi T, Okano Y, et al. (1999) Increased plasma levels of adrenomedullin in patients with pulmonary hypertension. Clin Sci 96:33-39
11. Kitamura K, Kangawa K, Kawamoto M, et al. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560
12. Kitamura K, Kato J, Kawamoto M, et al. (1998) The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun 244:551-555
13. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T (1993) Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 194:720-725
14. Kobayashi K, Kitamura K, Hirayama N, et al. (1996) Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J 131:676-680
15. Lainchbury JG, Nicholls MG, Espiner EA, Yandle TG, Lewis LK, Richards AM (1999) Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. Hypertension 34:70-75
16. Lippton H, Chang JK, Hao Q, Summer W, Hyman AL (1994) Adrenomedullin dilates the pulmonary vascular bed in vivo. J Appl Physiol 76:2154-2156
17. McGregor DO, Troughton RW, Frampton C, et al. (2001) Hypotensive and natriuretic actions of adrenomedullin in subjects with chronic renal impairment. Hypertension 37:1279-1284
18. McLatchie LM, Fraser NJ, Main MJ, et al. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339
19. Miyao Y, Nishikimi T, Goto Y, et al. (1998) Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart 79:39-44
20. Nagata D, Hirata Y, Suzuki E, et al. (1999) Hypoxia-induced adrenomedullin production in the kidney. Kidney Int 55:1259-1267
21. Nagaya N, Nishikimi T, Kyotoni S, et al. (1999) Pulmonary vasodilator responses to adrenomedullin in patients with pulmonary hypertension. Circulation 100:suppl1-240
22. Nagaya N, Nishikimi T, Uematsu M, et al. (2000) Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart 84:653-658
23. Nagaya N, Satoh T, Nishikimi T, et al. (2000) Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 101:498-503
24. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H, Hiramori K (1997) Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation 95:1214-1221
25. Nakayama M, Takahashi K, Murakami O, Shirato K, Shibahara S (1999) Induction of adrenomedullin by hypoxia in cultured human coronary artery endothelial cells. Peptides 20:769-772
26. Nishikimi T, Kitamura K, Saito Y, et al. (1994) Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 24:600-604
27. Nishikimi T, Nagata S, Sasaki T, et al. (1997) Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis. Heart 78:390-395
28. Nishikimi T, Saito Y, Kitamura K, et al. (1995) Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 26:1424-1431
29. Ohta H, Tsuji T, Asai S, et al. (1999) One-step direct assay for mature-type adonomedullin with monoclonal antibodies. Clin Chem 45:244-251
30. Ohta H, Tsuji T, Asai S, et al. (1999) A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma. Clin Chim Acta 287:131-143
31. Owji AA, Smith DM, Coppock HA, et al. (1995) An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 136:2127-2134
32. Samson WK (1999) Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu Rev Physiol 61:363-389
33. Sumimoto T, Nishikimi T, Mukai M, et al. (1997) Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension 30:741-745
34. Szokodi I, Kinnunen P, Tavi P, Weckstrom M, Toth M, Ruskoaho H (1998) Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 97:1062-1070
35. Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG (2000) Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension. Hypertension 36:588-593
36. Washimine H, Yamamoto Y, Kitamura K, et al. (1995) Plasma concentration of human adrenomedullin in patients on hemodialysis. Clin Nephrol 44:89-93
37. Yamaguchi T, Baba K, Doi Y, Yano K, Kitamura K, Eto T (1996) Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat. Hypertension 28:308-314
38. Yasue H, Yoshimura M, Sumida H, et al. (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90:195-203
39. Yoshibayashi M, Kamiya T, Kitamura K, et al. (1997) Plasma levels of adrenomedullin in primary and secondary pulmonary hypertension in patients < 20 years of age. Am J Cardiol 79:1556-1559